Update Management of Diabetes MellitusImportance of PPG control and Guidelines & recommendations on PPG controlInsulin faster aspart: the solid foundation from the molecular insight & ONSET® trialNon-comparable biologics vs originator insulin Risk and controversiesInitiation & Intensification of Insulin with BIAsp 30IDegAsp: The power of innovation & patient empowerment with simple co-formulationInsulin IDeg (Tresiba) overviewSUSTAIN Clinical Development ProgramExperiences with Liraglutide in Type-2 DMExplore the Next Generation Insulin Glargine– ToujeoRole of basal supported oral therapy (BOT) in diabetic patient managementCardio-Renal-Metabolic Outcomes with SGLT2- Inhibition Empowering the Foundation of T2DM CareInterpreting ADA Updates from Real World Evidence EMPRISE- Implications for Clinical PracticeUpdate in Practical management of DM during RamadanCOVID-19 and diabetes: a bad marriageImportance of Controlling Diabetes Early-“Metabolic Memory & Legacy Effect”: Evolving ConceptsUpdate in the management of Type-2 DM with SGLT-2 InhibitorsDulaglutide: Personalizing therapy to improve glycaemic and extra-glycaemic outcomesT2DM Management: Recommendation for COVID-19 & Safe Fasting During Ramadan